Psychiatric Times Editors

From a new FDA approval to treating “New Year depression” in patients, here are highlights from the week in Psychiatric Times.

From rare copy number variants in treatment-resistant psychosis to the psychiatric response to human trafficking, here are highlights from the week in Psychiatric Times.

Share your go-to methods for maintaining your mental health for a chance to be featured in our Wellbeing Checkup video series.

Write to us now to be part of our upcoming Black History Month series.

From the effects of caffeine on smokers with schizophrenia and bipolar disorder to the initiation of a trial for a new ADHD medication, here are highlights from the week in Psychiatric Times.

Out with the old and in with the new...

Revisiting the Special Reports featured in Psychiatric Times throughout 2022.

From new advances in the treatment of postpartum depression to digital therapeutics for the treatment of ADHD in children, here are highlights from the week in Psychiatric Times.

Revisiting the CME articles featured in Psychiatric Times in 2022.

Selections from the 2022 Psychiatric Times cover features.

What are you resolving to do in 2023?

The experts weighed in on a wide variety of psychiatric issues for the December 2022 issue of Psychiatric Times.

Incoming from the big man in red...

From current treatments for cannabis use disorder to new possibilities for the treatment of dementia, here are highlights from the week in Psychiatric Times.

From new legislation that would expand the US approach to mental health to drug abuse trends and treatment approaches for 2023, here are highlights from the week in Psychiatric Times.

What is your 2023 New Year's Resolution? We want to hear about it!

Survey results shed light on the effects of insomnia and obstacles to effective treatment.

From an in-depth analysis of ADHD in clinical practice to differences in effectiveness between intravenous and intranasal ketamine, here are highlights from the week in Psychiatric Times.

From evidence-based novel therapies for bipolar depression to potential indicators of early-stage Alzheimer disease, here are highlights from the week in Psychiatric Times.

The experts weighed in on a wide variety of psychiatric issues for the November 2022 issue of Psychiatric Times.

Tell us about your holiday traditions for a chance to be featured in our Holiday Traditions series.

From the unique challenges of treating physician-patients to updates on MDMA and psilocybin research and access, here are highlights from the week in Psychiatric Times.

In honor of Thanksgiving, Psychiatric Times shares some recent reflections on Thanksgiving and the value of gratitude and thankfulness.

From the cardiac adverse effects of lithium to the road to over-the-counter naloxone, here are highlights from the week in Psychiatric Times.

From the cross-cultural dimensions of psychosis to the economic burden of schizophrenia, here are highlights from the week in Psychiatric Times.

From the relationship between psychotic disorders and dementia risk to the major differences between bipolar I and bipolar II, here are highlights from the week in Psychiatric Times.

Catch up on the latest bipolar disorder research featured in Psychiatric Times.

The experts weighed in on a wide variety of psychiatric issues for the October 2022 issue of Psychiatric Times.

From complementary and alternative approaches in the COVID-19 era to mental health’s most toxic myth, here are highlights from the week in Psychiatric Times.

From herbal medicine for psychiatrists to the psychiatric implications of the Parkland School massing shooting, here are highlights from the week in Psychiatric Times.